Codexis, Inc. is a developer of biocatalysts. The Company is engaged in the pharmaceutical and fine chemical industries. The Company’s technology platform enables the evolution and optimization of biocatalysts to perform specific chemical reactions. The pharmaceutical customers use its technology, products and services in their manufacturing process development and production of drugs. The technology helps to develop biocatalysts for use in the fine chemicals markets, such as food, animal feed, polymers, flavors and fragrances and agricultural chemicals. The Company’s technologies enable scale-up and implementation of biocatalytic solutions for sustainable process development, from research to manufacturing. The Company’s products apply CodeEvolver directed evolution technology platform, which introduce genetic mutations into microorganisms, giving rise to changes in the enzymes.